Innovation in medicine: the first patient to receive gene therapy aimed at cell rejuvenation

publicat 2026-06-15 00:00:05 (Bursa)
The American biotechnology company Life Biosciences announced last week that it has administered the first experimental treatment ER-100 to a patient suffering from glaucoma, one of the main CAUSES of blindness. ...continuare.
EMAG


© Copyright 2000-2026 iStorm. Toate drepturile rezervate.